MESALAMINE

MESALAMINE was reported 28210 times

MESALAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 215 0.7096
1 CONGENITAL HIATUS HERNIA 150 0.6579
2 GRIP STRENGTH 107 0.4672
3 ANTACID THERAPY 48 0.3692
4 MALIGNANT MELANOMA STAGE 0 71 0.3397
5 STEROID DEPENDENCE 227 0.2585
6 SLEEP DISORDER THERAPY 49 0.2475
7 LUPUS VULGARIS 301 0.2389
8 SWOLLEN JOINT COUNT 54 0.2160
9 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 144 0.2156
10 CATARRH 181 0.2002
11 RETINITIS 312 0.1805
12 ANTICOAGULANT THERAPY 48 0.1690
13 MYOPERICARDITIS 130 0.1667
14 SERONEGATIVE ARTHRITIS 178 0.1553
15 COLITIS ULCERATIVE 6827 0.1526
16 FEMALE GENITAL TRACT FISTULA 260 0.1521
17 PROCTITIS 421 0.1501
18 THERAPEUTIC REACTION TIME DECREASED 434 0.1486
19 ANALGESIC THERAPY 47 0.1464
20 DEEP VEIN THROMBOSIS POSTOPERATIVE 285 0.1423
21 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 292 0.1408
22 OVERLAP SYNDROME 96 0.1371
23 FAECAL CALPROTECTIN INCREASED 406 0.1281
24 DISLOCATION OF VERTEBRA 292 0.1279
25 DRUG THERAPY 41 0.1209
26 MUCOUS STOOLS 596 0.1202
27 PORPHYRIA ACUTE 152 0.1059
28 BURNS SECOND DEGREE 185 0.1054
29 HEPATOSPLENIC T-CELL LYMPHOMA 38 0.1024
30 RECTAL TENESMUS 122 0.0979
31 FREQUENT BOWEL MOVEMENTS 2572 0.0951
32 SWOLLEN JOINT COUNT INCREASED 291 0.0912
33 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 50 0.0891
34 PROCTITIS ULCERATIVE 53 0.0879
35 CROHN'S DISEASE 602 0.0877
36 X-RAY ABNORMAL 157 0.0877
37 RADICULOPATHY 229 0.0868
38 TERMINAL ILEITIS 53 0.0863
39 FAECAL CALPROTECTIN ABNORMAL 35 0.0843
40 LOSS OF THERAPEUTIC RESPONSE 269 0.0843
41 DEFAECATION URGENCY 591 0.0843
42 BONE EROSION 283 0.0799
43 DRUG SPECIFIC ANTIBODY 104 0.0759
44 RHEUMATIC FEVER 331 0.0742
45 CHRONIC SINUSITIS 272 0.0724
46 DRUG LEVEL BELOW THERAPEUTIC 384 0.0695
47 MACULAR DEGENERATION 809 0.0677
48 HAEMATOCHEZIA 3734 0.0676
49 POUCHITIS 56 0.0650
50 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 59 0.0636
51 FACET JOINT SYNDROME 203 0.0623
52 MALIGNANT MELANOMA IN SITU 71 0.0573
53 LARGE INTESTINAL STENOSIS 112 0.0560
54 SMALL INTESTINAL STENOSIS 59 0.0554
55 BRONCHIECTASIS 368 0.0546
56 INTESTINAL ANASTOMOSIS 35 0.0543
57 HYPOPNOEA 188 0.0541
58 HYPERCHOLESTEROLAEMIA 515 0.0533
59 RECTAL ABSCESS 88 0.0524
60 ILEAL STENOSIS 91 0.0512
61 C-REACTIVE PROTEIN 47 0.0507
62 CYTOMEGALOVIRUS ENTEROCOLITIS 39 0.0506
63 ENTEROVESICAL FISTULA 38 0.0501
64 ANAL FISSURE 265 0.0494
65 DRUG LEVEL ABOVE THERAPEUTIC 225 0.0491
66 DRUG SPECIFIC ANTIBODY PRESENT 317 0.0487
67 DRUG LEVEL DECREASED 491 0.0482
68 RHEUMATOID FACTOR POSITIVE 278 0.0481
69 LUPUS-LIKE SYNDROME 424 0.0467
70 ANAL FISTULA 246 0.0461
71 CYTOMEGALOVIRUS COLITIS 106 0.0460
72 ALCOHOL POISONING 123 0.0459
73 DIARRHOEA HAEMORRHAGIC 428 0.0457
74 INTESTINAL FISTULA 64 0.0454
75 CHOLANGITIS SCLEROSING 93 0.0452
76 ANAL ABSCESS 240 0.0445
77 INTESTINAL STENOSIS 182 0.0431
78 DUODENAL ULCER PERFORATION 320 0.0430
79 FISTULA DISCHARGE 54 0.0428
80 RECTAL HAEMORRHAGE 1798 0.0418
81 WOUND INFECTION 454 0.0414
82 DRUG TOLERANCE DECREASED 116 0.0413
83 PERIPHERAL VENOUS DISEASE 167 0.0409
84 FAECES SOFT 296 0.0407
85 MUSCLE INJURY 335 0.0404
86 ENTEROCUTANEOUS FISTULA 35 0.0397
87 PROCTALGIA 253 0.0393
88 LARGE INTESTINAL ULCER 106 0.0390
89 SERUM FERRITIN DECREASED 67 0.0388
90 GASTROINTESTINAL INFLAMMATION 301 0.0384
91 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 272 0.0379
92 GRIP STRENGTH DECREASED 333 0.0378
93 HELICOBACTER INFECTION 377 0.0366
94 BREAST CANCER STAGE III 237 0.0366
95 GASTROINTESTINAL WALL THICKENING 54 0.0360
96 FOLLICULITIS 374 0.0356
97 MEDICATION RESIDUE PRESENT 170 0.0356
98 EXOSTOSIS 322 0.0352
99 ANORECTAL DISORDER 70 0.0351
100 AUTOIMMUNE DISORDER 340 0.0348
101 PERICARDITIS 581 0.0345
102 FISTULA 386 0.0343
103 JOINT DISLOCATION 360 0.0340
104 ANAL HAEMORRHAGE 95 0.0339
105 COLITIS 1242 0.0327
106 WALKING AID USER 215 0.0326
107 CLOSTRIDIUM DIFFICILE INFECTION 705 0.0323
108 SPONDYLITIS 117 0.0321
109 BENIGN PROSTATIC HYPERPLASIA 166 0.0321
110 C-REACTIVE PROTEIN ABNORMAL 206 0.0321
111 ERYTHEMA NODOSUM 110 0.0313
112 RED BLOOD CELL SEDIMENTATION RATE INCREASED 346 0.0312
113 HYPERPHOSPHATAEMIA 67 0.0311
114 POOR VENOUS ACCESS 319 0.0308
115 PERIRECTAL ABSCESS 34 0.0307
116 BREATH SOUNDS ABNORMAL 148 0.0300
117 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 190 0.0292
118 RHINITIS 235 0.0291
119 MATERNAL EXPOSURE TIMING UNSPECIFIED 109 0.0290
120 GASTROINTESTINAL BACTERIAL INFECTION 33 0.0289
121 LARGE INTESTINE POLYP 200 0.0288
122 IRON DEFICIENCY 129 0.0287
123 MATERNAL EXPOSURE DURING BREAST FEEDING 115 0.0283
124 ABSCESS INTESTINAL 61 0.0283
125 JOINT RANGE OF MOTION DECREASED 379 0.0282
126 DYSCHEZIA 86 0.0281
127 FOOT DEFORMITY 312 0.0281
128 HAND DEFORMITY 366 0.0279
129 INTESTINAL ULCER 44 0.0277
130 EXPOSURE TO SARS-COV-2 47 0.0276
131 EOSINOPHILIC PNEUMONIA 87 0.0276
132 PEMPHIGUS 341 0.0272
133 GASTROINTESTINAL OEDEMA 47 0.0266
134 ANORECTAL DISCOMFORT 141 0.0265
135 SECONDARY ADRENOCORTICAL INSUFFICIENCY 40 0.0265
136 ENDOMETRIOSIS 126 0.0264
137 IMPAIRED QUALITY OF LIFE 377 0.0262
138 GINGIVAL PAIN 208 0.0261
139 PAROSMIA 197 0.0261
140 ILEOSTOMY 66 0.0258
141 PLEURITIC PAIN 69 0.0250
142 PRODUCT RESIDUE PRESENT 134 0.0248
143 IRRITABLE BOWEL SYNDROME 527 0.0246
144 INTENTIONAL PRODUCT USE ISSUE 2141 0.0244
145 VAGINAL DISCHARGE 247 0.0244
146 ANAL INCONTINENCE 217 0.0241
147 CLOSTRIDIUM TEST POSITIVE 53 0.0240
148 ABDOMINAL ABSCESS 106 0.0240
149 CARDIAC MURMUR 205 0.0237
150 ABNORMAL FAECES 194 0.0237
151 APHTHOUS ULCER 182 0.0234
152 TUBULOINTERSTITIAL NEPHRITIS 424 0.0226
153 BODY TEMPERATURE FLUCTUATION 47 0.0225
154 PYODERMA GANGRENOSUM 81 0.0225
155 INFLAMMATORY BOWEL DISEASE 220 0.0225
156 BOWEL MOVEMENT IRREGULARITY 170 0.0222
157 INJECTION SITE PAPULE 101 0.0220
158 ABDOMINAL ADHESIONS 69 0.0218
159 VEIN RUPTURE 36 0.0215
160 LIP DRY 195 0.0214
161 SCIATICA 331 0.0207
162 RESPIRATORY SYMPTOM 59 0.0207
163 BLOOD PRESSURE FLUCTUATION 493 0.0205
164 MYOCARDITIS 234 0.0204
165 BLOOD PRESSURE DIASTOLIC INCREASED 94 0.0203
166 HEPATIC CIRRHOSIS 381 0.0203
167 ORAL CANDIDIASIS 265 0.0201
168 PUSTULAR PSORIASIS 68 0.0198
169 PARAESTHESIA ORAL 284 0.0197
170 DISSEMINATED TUBERCULOSIS 50 0.0195
171 PREGNANCY 387 0.0193
172 FEAR OF DISEASE 34 0.0191
173 SOCIAL PROBLEM 79 0.0191
174 SPINAL FUSION SURGERY 77 0.0190
175 CLOSTRIDIAL INFECTION 64 0.0189
176 INFREQUENT BOWEL MOVEMENTS 47 0.0189
177 SYNOVITIS 337 0.0187
178 BLOOD PRESSURE DIASTOLIC DECREASED 137 0.0185
179 HAEMORRHOIDS 361 0.0185
180 WOUND 517 0.0185
181 LIVE BIRTH 154 0.0184
182 SUBILEUS 38 0.0182
183 SYSTEMIC LUPUS ERYTHEMATOSUS 645 0.0182
184 PULMONARY FIBROSIS 348 0.0181
185 GLOSSODYNIA 401 0.0179
186 HIP ARTHROPLASTY 274 0.0179
187 LARGE INTESTINAL HAEMORRHAGE 40 0.0178
188 BURSITIS 216 0.0178
189 INABILITY TO AFFORD MEDICATION 176 0.0177
190 INFUSION RELATED REACTION 1168 0.0176
191 WEIGHT FLUCTUATION 182 0.0174
192 RECTAL DISCHARGE 64 0.0174
193 FAECES HARD 67 0.0172
194 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 40 0.0172
195 JOINT STIFFNESS 449 0.0171
196 GASTROINTESTINAL INFECTION 153 0.0171
197 IMPAIRED HEALING 560 0.0170
198 SMALL INTESTINAL OBSTRUCTION 208 0.0169
199 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 40 0.0168
200 COLECTOMY 95 0.0168
201 C-REACTIVE PROTEIN INCREASED 610 0.0167
202 LOWER LIMB FRACTURE 322 0.0167
203 DISCOURAGEMENT 39 0.0167
204 BLOOD IRON DECREASED 196 0.0165
205 IRON DEFICIENCY ANAEMIA 152 0.0165
206 LACTOSE INTOLERANCE 42 0.0164
207 ABDOMINAL PAIN 3788 0.0163
208 ABSCESS 259 0.0162
209 FIBROMYALGIA 394 0.0162
210 LARGE INTESTINAL OBSTRUCTION 36 0.0161
211 EAR INFECTION 427 0.0160
212 BODY TEMPERATURE DECREASED 156 0.0158
213 MICTURITION URGENCY 180 0.0157
214 PRESCRIBED OVERDOSE 303 0.0156
215 APPENDICITIS 146 0.0156
216 CONDITION AGGRAVATED 4701 0.0154
217 IMPAIRED WORK ABILITY 325 0.0152
218 INFLAMMATORY MARKER INCREASED 75 0.0151
219 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 76 0.0150
220 LIVER INJURY 367 0.0149
221 ABDOMINAL MASS 40 0.0149
222 ENTERITIS 95 0.0148
223 GASTROINTESTINAL PAIN 163 0.0148
224 GASTROINTESTINAL SOUNDS ABNORMAL 73 0.0147
225 THERAPEUTIC RESPONSE SHORTENED 488 0.0147
226 PULMONARY TUBERCULOSIS 62 0.0145
227 INTESTINAL RESECTION 78 0.0145
228 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 692 0.0144
229 FULL BLOOD COUNT ABNORMAL 152 0.0144
230 ORGANISING PNEUMONIA 71 0.0143
231 PRESCRIBED UNDERDOSE 285 0.0143
232 HEART RATE DECREASED 500 0.0142
233 CUSHINGOID 45 0.0140
234 INTESTINAL OBSTRUCTION 524 0.0139
235 PANCREATITIS ACUTE 312 0.0139
236 INFUSION SITE EXTRAVASATION 86 0.0138
237 SUBCUTANEOUS ABSCESS 66 0.0138
238 ABDOMINAL TENDERNESS 68 0.0137
239 PLEURISY 81 0.0136
240 PREMATURE LABOUR 77 0.0136
241 ABNORMAL LOSS OF WEIGHT 92 0.0135
242 RASH VESICULAR 65 0.0134
243 PRODUCT AVAILABILITY ISSUE 297 0.0130
244 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 926 0.0130
245 PROCEDURAL PAIN 361 0.0130
246 TYPE 2 DIABETES MELLITUS 437 0.0130
247 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 93 0.0130
248 GROWTH RETARDATION 38 0.0129
249 VITAMIN B12 DECREASED 37 0.0128
250 TYPE IV HYPERSENSITIVITY REACTION 35 0.0128
251 KNEE ARTHROPLASTY 267 0.0127
252 CLOSTRIDIUM DIFFICILE COLITIS 134 0.0126
253 ABDOMINAL PAIN LOWER 319 0.0126
254 SERUM SICKNESS 35 0.0125
255 PANCREATITIS 654 0.0124
256 HAEMORRHAGIC DIATHESIS 44 0.0123
257 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2227 0.0123
258 APPENDICECTOMY 44 0.0123
259 FLATULENCE 691 0.0122
260 LIVER FUNCTION TEST INCREASED 261 0.0121
261 ARTHRITIS 951 0.0121
262 COLITIS MICROSCOPIC 57 0.0120
263 SKIN WARM 70 0.0120
264 BLOOD ALBUMIN DECREASED 95 0.0120
265 OSTEOARTHRITIS 504 0.0119
266 NIGHT SWEATS 382 0.0118
267 THERAPY NON-RESPONDER 532 0.0118
268 RED CELL DISTRIBUTION WIDTH INCREASED 49 0.0118
269 INFLAMMATION 608 0.0118
270 LARGE INTESTINE PERFORATION 81 0.0117
271 POLYP 76 0.0116
272 UVEITIS 157 0.0116
273 SUSPECTED OFF LABEL USE 52 0.0115
274 OSTEOPOROSIS 466 0.0113
275 HAEMORRHOIDAL HAEMORRHAGE 55 0.0113
276 VAGINAL INFECTION 53 0.0113
277 CYTOMEGALOVIRUS INFECTION 186 0.0112
278 ANTINUCLEAR ANTIBODY POSITIVE 36 0.0111
279 TONGUE OEDEMA 42 0.0110
280 LOWER RESPIRATORY TRACT INFECTION 485 0.0107
281 FOOD INTOLERANCE 39 0.0106
282 DRUG-INDUCED LIVER INJURY 333 0.0106
283 OFF LABEL USE 9285 0.0106
284 LIPASE INCREASED 81 0.0106
285 INSURANCE ISSUE 161 0.0105
286 ABDOMINAL HERNIA 48 0.0105
287 INGUINAL HERNIA 64 0.0105
288 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 179 0.0104
289 HYPOPHOSPHATAEMIA 77 0.0104
290 UPPER RESPIRATORY TRACT INFECTION 481 0.0104
291 DIVERTICULUM INTESTINAL 45 0.0103
292 MALNUTRITION 115 0.0103
293 ULCER 162 0.0102
294 HEART RATE IRREGULAR 230 0.0102
295 PHARYNGITIS STREPTOCOCCAL 110 0.0102
296 WEIGHT DECREASED 2833 0.0101
297 FURUNCLE 80 0.0101
298 POSTOPERATIVE WOUND INFECTION 68 0.0101
299 INTESTINAL PERFORATION 112 0.0100
300 DRUG EFFECT LESS THAN EXPECTED 147 0.0099
301 ROAD TRAFFIC ACCIDENT 413 0.0099
302 JOINT INJURY 210 0.0098
303 CONGENITAL ANOMALY 76 0.0098
304 OBESITY 156 0.0098
305 MACULOPATHY 34 0.0096
306 ABDOMINAL DISTENSION 996 0.0095
307 WHITE BLOOD CELL COUNT INCREASED 366 0.0095
308 DEMYELINATION 39 0.0095
309 SINUSITIS 975 0.0095
310 DELIRIUM 329 0.0095
311 SKIN PAPILLOMA 38 0.0095
312 BLOOD PRESSURE SYSTOLIC INCREASED 184 0.0094
313 DIVERTICULUM 67 0.0094
314 PSORIATIC ARTHROPATHY 382 0.0094
315 TONSILLITIS 49 0.0094
316 TREATMENT FAILURE 776 0.0094
317 WHEEZING 555 0.0093
318 FOOD POISONING 50 0.0093
319 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 158 0.0093
320 POLYARTHRITIS 49 0.0093
321 BLOOD CHOLESTEROL INCREASED 433 0.0093
322 OBSTRUCTIVE AIRWAYS DISORDER 103 0.0093
323 DISABILITY 183 0.0092
324 PARANASAL SINUS DISCOMFORT 35 0.0092
325 VITAMIN D DECREASED 79 0.0092
326 APPETITE DISORDER 61 0.0092
327 TROPONIN INCREASED 70 0.0092
328 ILEUS 114 0.0092
329 STREPTOCOCCAL INFECTION 51 0.0092
330 GASTROINTESTINAL MOTILITY DISORDER 49 0.0091
331 OBSTRUCTION 36 0.0090
332 ENTEROCOLITIS 52 0.0090
333 TOOTH INFECTION 118 0.0089
334 NEPHROLITHIASIS 409 0.0089
335 GASTROENTERITIS 130 0.0089
336 DISCOMFORT 541 0.0089
337 LIGAMENT RUPTURE 39 0.0088
338 THERAPEUTIC PRODUCT EFFECT DELAYED 40 0.0088
339 SWOLLEN TONGUE 273 0.0087
340 GAIT INABILITY 292 0.0087
341 BASAL CELL CARCINOMA 136 0.0087
342 CHOLANGITIS 54 0.0087
343 PYREXIA 2999 0.0087
344 DIVERTICULITIS 240 0.0087
345 EPSTEIN-BARR VIRUS INFECTION 54 0.0086
346 EAR PAIN 168 0.0086
347 HYPOALBUMINAEMIA 67 0.0086
348 DYSPEPSIA 846 0.0086
349 MYASTHENIA GRAVIS 69 0.0085
350 THERAPEUTIC PRODUCT EFFECT DECREASED 379 0.0085
351 FAECES DISCOLOURED 183 0.0084
352 NASOPHARYNGITIS 1554 0.0084
353 BLEPHAROSPASM 53 0.0084
354 VITAMIN B12 DEFICIENCY 34 0.0084
355 UMBILICAL HERNIA 39 0.0083
356 OEDEMA 451 0.0083
357 PHARYNGITIS 103 0.0083
358 HEPATIC ENZYME INCREASED 566 0.0083
359 GENERAL SYMPTOM 62 0.0083
360 MIGRAINE 789 0.0083
361 INJECTION SITE HAEMATOMA 119 0.0082
362 OROPHARYNGEAL PAIN 757 0.0082
363 LUNG DISORDER 399 0.0081
364 BLISTER 457 0.0081
365 ARTHROPATHY 452 0.0081
366 FEAR OF INJECTION 58 0.0081
367 LIVER DISORDER 360 0.0081
368 THERAPY PARTIAL RESPONDER 126 0.0081
369 MATERNAL EXPOSURE DURING PREGNANCY 719 0.0081
370 MALABSORPTION 42 0.0080
371 GASTROINTESTINAL DISORDER 716 0.0080
372 HYPERLIPIDAEMIA 95 0.0079
373 WEIGHT INCREASED 1777 0.0079
374 UTERINE LEIOMYOMA 58 0.0079
375 BACTERIAL INFECTION 148 0.0079
376 ESCHERICHIA INFECTION 65 0.0079
377 MUSCULOSKELETAL STIFFNESS 685 0.0078
378 ARTHRITIS INFECTIVE 36 0.0078
379 DIARRHOEA 5004 0.0077
380 SINUS CONGESTION 104 0.0077
381 BLOOD TEST ABNORMAL 108 0.0077
382 BLOOD CALCIUM INCREASED 67 0.0076
383 MELAENA 168 0.0076
384 GESTATIONAL DIABETES 36 0.0075
385 DRUG INTOLERANCE 728 0.0075
386 COVID-19 1318 0.0075
387 RESPIRATORY TRACT CONGESTION 119 0.0075
388 MYOSITIS 67 0.0075
389 DERMATITIS ACNEIFORM 45 0.0074
390 IMMUNOSUPPRESSION 65 0.0074
391 MOUTH ULCERATION 155 0.0073
392 ABDOMINAL DISCOMFORT 1233 0.0073
393 ARTHROPOD BITE 54 0.0073
394 FAECAL INCONTINENCE 35 0.0073
395 ASPIRATION 79 0.0072
396 ARTHRALGIA 2979 0.0072
397 FLANK PAIN 67 0.0071
398 CHROMATURIA 161 0.0071
399 BRONCHITIS 526 0.0071
400 SECRETION DISCHARGE 89 0.0071
401 PRODUCTIVE COUGH 339 0.0071
402 BLOOD PRESSURE INCREASED 1084 0.0071
403 INCREASED TENDENCY TO BRUISE 65 0.0071
404 MOBILITY DECREASED 507 0.0070
405 SYMPTOM RECURRENCE 42 0.0070
406 SPUTUM DISCOLOURED 66 0.0070
407 NASAL CONGESTION 407 0.0069
408 BODY TEMPERATURE INCREASED 141 0.0069
409 INJECTION SITE NODULE 76 0.0069
410 PLATELET COUNT INCREASED 90 0.0069
411 TINNITUS 317 0.0069
412 FEELING HOT 416 0.0068
413 PRODUCT USE ISSUE 1273 0.0068
414 POST PROCEDURAL INFECTION 55 0.0068
415 STOMATITIS 410 0.0068
416 ABDOMINAL PAIN UPPER 1383 0.0067
417 DYSLIPIDAEMIA 34 0.0067
418 DEEP VEIN THROMBOSIS 435 0.0067
419 RASH PAPULAR 150 0.0067
420 VITAMIN D DEFICIENCY 65 0.0067
421 ULCER HAEMORRHAGE 45 0.0066
422 GASTROENTERITIS VIRAL 120 0.0066
423 TENDERNESS 69 0.0066
424 SINUS HEADACHE 39 0.0066
425 PALLOR 178 0.0065
426 CONTUSION 628 0.0065
427 ECZEMA 341 0.0065
428 PNEUMOCYSTIS JIROVECII PNEUMONIA 65 0.0065
429 MUSCULOSKELETAL PAIN 339 0.0065
430 AUTOIMMUNE HEPATITIS 45 0.0065
431 NEUTROPHIL COUNT INCREASED 66 0.0064
432 RHINORRHOEA 416 0.0064
433 INJURY 451 0.0064
434 SARS-COV-2 TEST POSITIVE 84 0.0064
435 INFUSION SITE SWELLING 40 0.0064
436 ASTHMA 716 0.0063
437 FRUSTRATION TOLERANCE DECREASED 51 0.0063
438 HERNIA 122 0.0063
439 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 447 0.0063
440 HYPOAESTHESIA 938 0.0063
441 TRANSIENT ISCHAEMIC ATTACK 210 0.0062
442 PULMONARY TOXICITY 44 0.0062
443 NIGHTMARE 215 0.0062
444 INFUSION SITE PAIN 80 0.0062
445 BLOOD POTASSIUM DECREASED 186 0.0062
446 MENISCUS INJURY 38 0.0062
447 INFECTION 890 0.0061
448 AMNESIA 397 0.0061
449 EXPOSURE DURING PREGNANCY 378 0.0061
450 INTERSTITIAL LUNG DISEASE 292 0.0060
451 OEDEMA PERIPHERAL 733 0.0060
452 HEPATIC STEATOSIS 112 0.0060
453 JOINT SWELLING 724 0.0060
454 INJECTION SITE EXTRAVASATION 74 0.0060
455 ACCIDENTAL OVERDOSE 219 0.0060
456 FOETAL GROWTH RESTRICTION 36 0.0059
457 VERTIGO 360 0.0059
458 HYPOPHAGIA 151 0.0059
459 RASH PUSTULAR 43 0.0059
460 MEDICATION ERROR 328 0.0059
461 HAEMATOCRIT DECREASED 117 0.0059
462 HAEMOGLOBIN DECREASED 601 0.0058
463 MALAISE 2566 0.0058
464 ANAEMIA 1109 0.0058
465 CELLULITIS 292 0.0058
466 SKIN INFECTION 65 0.0058
467 INJECTION SITE VESICLES 35 0.0058
468 BREAST CANCER STAGE II 48 0.0058
469 ANKYLOSING SPONDYLITIS 76 0.0058
470 CONSTIPATION 1256 0.0058
471 PULMONARY EMBOLISM 547 0.0058
472 RESPIRATORY DISORDER 172 0.0057
473 HERPES ZOSTER 330 0.0057
474 VIRAL INFECTION 191 0.0057
475 SLEEP DISORDER 404 0.0057
476 ALOPECIA 1123 0.0057
477 IMMUNODEFICIENCY 85 0.0057
478 GENERAL PHYSICAL HEALTH DETERIORATION 659 0.0057
479 INCONTINENCE 60 0.0057
480 CHOLELITHIASIS 186 0.0057
481 HYPERTENSION 1200 0.0057
482 GOUT 101 0.0056
483 CORONARY ARTERY DISEASE 170 0.0056
484 CHILLS 655 0.0056
485 GASTROOESOPHAGEAL REFLUX DISEASE 448 0.0056
486 LYMPHADENOPATHY 197 0.0056
487 END STAGE RENAL DISEASE 101 0.0055
488 INJECTION SITE HAEMORRHAGE 442 0.0055
489 DRUG INEFFECTIVE 7291 0.0055
490 INFLUENZA 615 0.0055
491 PERICARDIAL EFFUSION 127 0.0055
492 EYE INFECTION 62 0.0055
493 PNEUMONIA BACTERIAL 50 0.0054
494 HAEMORRHAGE 569 0.0054
495 SNEEZING 122 0.0054
496 OROPHARYNGEAL DISCOMFORT 49 0.0054
497 CAESAREAN SECTION 63 0.0054
498 CHEST PAIN 1001 0.0054
499 URTICARIA 905 0.0054
500 EOSINOPHIL COUNT INCREASED 45 0.0054
501 HYPERSENSITIVITY 1001 0.0054
502 TACHYCARDIA 479 0.0054
503 WRONG TECHNIQUE IN DRUG USAGE PROCESS 195 0.0054
504 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 280 0.0054
505 LABORATORY TEST ABNORMAL 158 0.0053
506 SWELLING 498 0.0053
507 DRUG LEVEL INCREASED 88 0.0053
508 PYELONEPHRITIS 46 0.0053
509 SKIN DISORDER 177 0.0053
510 DEHYDRATION 707 0.0053
511 CONCUSSION 41 0.0053
512 RESPIRATORY RATE INCREASED 47 0.0053
513 RENAL CYST 42 0.0053
514 INJECTION SITE PRURITUS 354 0.0053
515 STAPHYLOCOCCAL INFECTION 174 0.0053
516 NEURALGIA 128 0.0053
517 RASH MACULAR 184 0.0053
518 INJECTION SITE URTICARIA 129 0.0053
519 RASH PRURITIC 284 0.0052
520 PERIPHERAL SWELLING 807 0.0052
521 PULMONARY MASS 78 0.0052
522 INJECTION SITE PAIN 1604 0.0052
523 UPPER-AIRWAY COUGH SYNDROME 43 0.0052
524 TOOTH ABSCESS 53 0.0052
525 MUSCULAR WEAKNESS 590 0.0052
526 PRODUCT DISTRIBUTION ISSUE 48 0.0052
527 MUSCLE SPASMS 947 0.0052
528 EYE INFLAMMATION 49 0.0051
529 PAPULE 36 0.0051
530 HEADACHE 3200 0.0051
531 INFLUENZA LIKE ILLNESS 420 0.0051
532 DECREASED APPETITE 1185 0.0051
533 BLOOD MAGNESIUM DECREASED 44 0.0051
534 INJECTION SITE BRUISING 405 0.0051
535 DIFFUSE LARGE B-CELL LYMPHOMA 39 0.0051
536 FATIGUE 3923 0.0050
537 MALIGNANT MELANOMA 67 0.0050
538 CARPAL TUNNEL SYNDROME 70 0.0050
539 AORTIC ANEURYSM 38 0.0050
540 SENSATION OF FOREIGN BODY 42 0.0050
541 ORAL HERPES 97 0.0050
542 ATELECTASIS 48 0.0050
543 PNEUMONIA 1608 0.0050
544 DYSPNOEA EXERTIONAL 187 0.0050
545 INJECTION SITE WARMTH 102 0.0050
546 HEART RATE INCREASED 487 0.0049
547 OVARIAN CYST 49 0.0049
548 HIATUS HERNIA 63 0.0049
549 GASTRITIS 128 0.0049
550 ILL-DEFINED DISORDER 294 0.0048
551 VISUAL IMPAIRMENT 597 0.0048
552 SEASONAL ALLERGY 68 0.0048
553 POST PROCEDURAL COMPLICATION 92 0.0048
554 BLOOD PRESSURE DECREASED 318 0.0048
555 RHEUMATOID ARTHRITIS 543 0.0048
556 ASTHENIA 1796 0.0048
557 EAR DISCOMFORT 49 0.0048
558 ROTATOR CUFF SYNDROME 61 0.0047
559 LOWER GASTROINTESTINAL HAEMORRHAGE 35 0.0047
560 INJECTION SITE IRRITATION 60 0.0047
561 PAIN IN EXTREMITY 1386 0.0047
562 COLON CANCER 70 0.0047
563 NAIL DISORDER 41 0.0047
564 CONFUSIONAL STATE 757 0.0047
565 HYDRONEPHROSIS 35 0.0047
566 PARAESTHESIA 735 0.0047
567 WRIST FRACTURE 56 0.0047
568 UNDERDOSE 341 0.0047
569 NERVE COMPRESSION 43 0.0047
570 CONTRAINDICATED PRODUCT ADMINISTERED 141 0.0047
571 CYSTITIS 148 0.0046
572 SKIN CANCER 100 0.0046
573 INCORRECT DOSE ADMINISTERED 1059 0.0046
574 DISEASE RECURRENCE 220 0.0046
575 EOSINOPHILIA 81 0.0046
576 ADRENAL INSUFFICIENCY 56 0.0046
577 HYPOMAGNESAEMIA 64 0.0046
578 EATING DISORDER 97 0.0046
579 LIGAMENT SPRAIN 45 0.0045
580 DRY MOUTH 369 0.0045
581 ILLNESS 468 0.0045
582 FEEDING DISORDER 92 0.0045
583 DEPRESSION 1028 0.0045
584 LOCALISED INFECTION 109 0.0045
585 SKIN LACERATION 49 0.0045
586 PAIN 2761 0.0045
587 ABORTION SPONTANEOUS 180 0.0045
588 FEELING COLD 125 0.0045
589 VOMITING 2103 0.0045
590 BACTERAEMIA 53 0.0045
591 VASCULITIS 52 0.0045
592 INJECTION SITE ERYTHEMA 552 0.0044
593 SCAR 76 0.0044
594 ADVERSE DRUG REACTION 398 0.0044
595 ANXIETY 1256 0.0044
596 SKIN LESION 121 0.0044
597 PSORIASIS 575 0.0044
598 SCAB 50 0.0044
599 NECK PAIN 245 0.0044
600 COELIAC DISEASE 43 0.0044
601 COUGH 1225 0.0044
602 POOR QUALITY SLEEP 94 0.0044
603 PALPITATIONS 510 0.0044
604 BRAIN FOG 68 0.0043
605 LYMPHOMA 67 0.0043
606 BACK INJURY 47 0.0043
607 BACK PAIN 1004 0.0043
608 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 237 0.0043
609 TRANSAMINASES INCREASED 96 0.0043
610 LEUKOCYTOSIS 78 0.0043
611 LOCAL SWELLING 75 0.0043
612 APHONIA 60 0.0043
613 MYALGIA 729 0.0043
614 LOW BIRTH WEIGHT BABY 34 0.0043
615 HIDRADENITIS 39 0.0043
616 NAUSEA 3373 0.0043
617 INJECTION SITE SWELLING 326 0.0043
618 PHOTOPHOBIA 80 0.0042
619 PREMATURE BABY 128 0.0042
620 SQUAMOUS CELL CARCINOMA 40 0.0042
621 MASS 59 0.0042
622 ELECTROLYTE IMBALANCE 49 0.0042
623 CHOLECYSTECTOMY 48 0.0042
624 CATARACT 248 0.0042
625 PANCYTOPENIA 232 0.0041
626 CANDIDA INFECTION 70 0.0041
627 AGRANULOCYTOSIS 77 0.0041
628 URINARY TRACT INFECTION 704 0.0041
629 RASH 1797 0.0041
630 GASTRIC ULCER 78 0.0041
631 ERYTHEMA 843 0.0041
632 BREAST CANCER STAGE I 38 0.0041
633 TOOTHACHE 74 0.0041
634 LUNG INFILTRATION 36 0.0041
635 DECUBITUS ULCER 33 0.0040
636 BLOOD URINE PRESENT 76 0.0040
637 INJECTION SITE DISCOLOURATION 50 0.0040
638 RASH ERYTHEMATOUS 191 0.0040
639 SINUS DISORDER 79 0.0040
640 SWELLING FACE 258 0.0040
641 MUSCLE ATROPHY 50 0.0039
642 INJECTION SITE RASH 121 0.0039
643 HYPOKALAEMIA 182 0.0039
644 MUSCLE STRAIN 34 0.0039
645 CARDIOMYOPATHY 58 0.0039
646 FACIAL PAIN 35 0.0039
647 DYSGEUSIA 291 0.0039
648 ACNE 296 0.0039
649 MEMORY IMPAIRMENT 536 0.0039
650 THROMBOSIS 313 0.0039
651 PHOTOSENSITIVITY REACTION 64 0.0039
652 PRODUCT USE COMPLAINT 61 0.0039
653 CYST 48 0.0039
654 PERIPHERAL COLDNESS 53 0.0039
655 MUSCULOSKELETAL DISCOMFORT 66 0.0038
656 THROAT IRRITATION 172 0.0038
657 BLOOD PRESSURE ABNORMAL 76 0.0038
658 INTERVERTEBRAL DISC PROTRUSION 83 0.0038
659 CHEST DISCOMFORT 387 0.0038
660 INTENTIONAL DOSE OMISSION 107 0.0037
661 OESOPHAGITIS 41 0.0037
662 CORONARY ARTERY OCCLUSION 51 0.0037
663 RED BLOOD CELL COUNT DECREASED 106 0.0037
664 BLOOD ALKALINE PHOSPHATASE INCREASED 92 0.0037
665 RIB FRACTURE 76 0.0037
666 CHOLECYSTITIS 44 0.0037
667 FUNGAL INFECTION 123 0.0037
668 BACK DISORDER 60 0.0037
669 RESPIRATORY TRACT INFECTION 96 0.0037
670 TENDONITIS 57 0.0037
671 KIDNEY INFECTION 72 0.0037
672 PRODUCT PHYSICAL ISSUE 74 0.0037
673 ORAL PAIN 82 0.0037
674 DRUG EFFECT INCOMPLETE 133 0.0037
675 SEPSIS 407 0.0036
676 PLEURAL EFFUSION 222 0.0036
677 COLD SWEAT 64 0.0036
678 PRURITUS 1394 0.0036
679 BLADDER DISORDER 36 0.0036
680 VENTRICULAR FIBRILLATION 40 0.0036
681 MULTIPLE ORGAN DYSFUNCTION SYNDROME 102 0.0036
682 DIZZINESS 1794 0.0036
683 GAIT DISTURBANCE 685 0.0036
684 DEVICE RELATED INFECTION 55 0.0036
685 IMMUNE SYSTEM DISORDER 47 0.0036
686 THERAPEUTIC RESPONSE DECREASED 216 0.0036
687 HEAD DISCOMFORT 63 0.0036
688 BLOOD SODIUM DECREASED 67 0.0036
689 THROAT TIGHTNESS 96 0.0035
690 POOR QUALITY PRODUCT ADMINISTERED 37 0.0035
691 NERVE INJURY 39 0.0035
692 OXYGEN SATURATION DECREASED 197 0.0035
693 SPLENOMEGALY 41 0.0035
694 RENAL PAIN 37 0.0035
695 PREMATURE DELIVERY 55 0.0035
696 PRODUCT USE IN UNAPPROVED INDICATION 855 0.0034
697 POST PROCEDURAL HAEMORRHAGE 40 0.0034
698 OSTEOPENIA 52 0.0034
699 DERMATITIS ALLERGIC 43 0.0034
700 DEVICE MALFUNCTION 238 0.0034
701 OCULAR DISCOMFORT 38 0.0034
702 FACE OEDEMA 57 0.0034
703 BLOOD CALCIUM DECREASED 38 0.0034
704 TOOTH DISORDER 75 0.0034
705 PRESYNCOPE 82 0.0034
706 DIABETES MELLITUS 257 0.0034
707 DYSURIA 124 0.0034
708 ACCIDENT 40 0.0033
709 DENTAL CARIES 37 0.0033
710 PRODUCT ODOUR ABNORMAL 35 0.0033
711 LIVER FUNCTION TEST ABNORMAL 97 0.0033
712 PERITONITIS 69 0.0033
713 DRUG EFFECT DECREASED 179 0.0033
714 PELVIC PAIN 60 0.0033
715 NODULE 43 0.0033
716 NERVOUSNESS 172 0.0033
717 LIMB INJURY 89 0.0033
718 BEDRIDDEN 43 0.0033
719 TREATMENT NONCOMPLIANCE 178 0.0033
720 GAMMA-GLUTAMYLTRANSFERASE INCREASED 72 0.0032
721 SEPTIC SHOCK 141 0.0032
722 INSOMNIA 863 0.0032
723 LETHARGY 186 0.0032
724 MUSCULOSKELETAL CHEST PAIN 50 0.0032
725 LYMPHOCYTE COUNT DECREASED 57 0.0032
726 DYSPNOEA 1821 0.0032
727 PULMONARY THROMBOSIS 35 0.0032
728 PNEUMONITIS 87 0.0032
729 GALLBLADDER DISORDER 57 0.0032
730 ASCITES 93 0.0032
731 PNEUMOTHORAX 50 0.0031
732 PARALYSIS 45 0.0031
733 PANIC ATTACK 114 0.0031
734 FOETAL EXPOSURE DURING PREGNANCY 254 0.0031
735 FOOT FRACTURE 59 0.0031
736 INJECTION SITE REACTION 213 0.0031
737 TOOTH FRACTURE 34 0.0031
738 ACUTE MYELOID LEUKAEMIA 48 0.0031
739 DRUG RESISTANCE 79 0.0031
740 CONJUNCTIVITIS 57 0.0031
741 LEUKOPENIA 153 0.0031
742 DERMATITIS 64 0.0031
743 HAEMOPTYSIS 85 0.0030
744 HYPERTHYROIDISM 44 0.0030
745 HAEMATEMESIS 77 0.0030
746 DRUG EXPOSURE DURING PREGNANCY 103 0.0030
747 GASTROINTESTINAL HAEMORRHAGE 253 0.0030
748 CHRONIC KIDNEY DISEASE 230 0.0030
749 DYSPHAGIA 286 0.0030
750 HEPATITIS 77 0.0030
751 LIP SWELLING 100 0.0030
752 ASPARTATE AMINOTRANSFERASE INCREASED 159 0.0030
753 QUALITY OF LIFE DECREASED 40 0.0030
754 DERMATITIS CONTACT 34 0.0030
755 INTERNAL HAEMORRHAGE 34 0.0030
756 INTRAOCULAR PRESSURE INCREASED 38 0.0030
757 INCORRECT PRODUCT STORAGE 39 0.0030
758 SOMNOLENCE 597 0.0030
759 POLLAKIURIA 123 0.0029
760 FLUID RETENTION 150 0.0029
761 SYNCOPE 295 0.0029
762 FLUSHING 298 0.0029
763 INJECTION SITE INDURATION 38 0.0029
764 THINKING ABNORMAL 54 0.0029
765 ALANINE AMINOTRANSFERASE INCREASED 177 0.0029
766 SLEEP APNOEA SYNDROME 55 0.0029
767 DEVICE ISSUE 258 0.0029
768 DYSPHONIA 168 0.0029
769 HEPATIC FUNCTION ABNORMAL 107 0.0029
770 HYPERHIDROSIS 369 0.0029
771 DEPRESSED MOOD 151 0.0029
772 DIPLOPIA 74 0.0028
773 NO ADVERSE EVENT 514 0.0028
774 CARDIOVASCULAR DISORDER 72 0.0028
775 PRODUCT DOSE OMISSION ISSUE 834 0.0028
776 LUNG INFECTION 44 0.0028
777 UNEVALUABLE EVENT 214 0.0028
778 TASTE DISORDER 57 0.0028
779 ANAPHYLACTIC REACTION 155 0.0028
780 JAUNDICE 75 0.0028
781 LIMB DISCOMFORT 86 0.0028
782 OSTEOMYELITIS 50 0.0028
783 DRUG DOSE OMISSION 456 0.0028
784 LYMPHOPENIA 39 0.0028
785 SURGERY 161 0.0027
786 HYPONATRAEMIA 154 0.0027
787 HYPOAESTHESIA ORAL 41 0.0027
788 EPILEPSY 83 0.0027
789 BURNING SENSATION 189 0.0027
790 HEPATOTOXICITY 60 0.0027
791 PRURITUS GENERALISED 58 0.0027
792 HOT FLUSH 202 0.0027
793 SENSORY DISTURBANCE 43 0.0027
794 GENERALISED OEDEMA 33 0.0027
795 RASH GENERALISED 69 0.0027
796 FEELING ABNORMAL 638 0.0027
797 MUSCLE TIGHTNESS 43 0.0027
798 ADVERSE EVENT 244 0.0026
799 RESTLESS LEGS SYNDROME 48 0.0026
800 SKIN ULCER 68 0.0026
801 THIRST 47 0.0026
802 HAEMATURIA 90 0.0026
803 DISSEMINATED INTRAVASCULAR COAGULATION 37 0.0026
804 BONE MARROW FAILURE 53 0.0026
805 HEAD INJURY 82 0.0026
806 BLOOD LACTATE DEHYDROGENASE INCREASED 41 0.0026
807 ANKLE FRACTURE 40 0.0026
808 EYE SWELLING 96 0.0026
809 RENAL IMPAIRMENT 215 0.0026
810 CEREBROVASCULAR ACCIDENT 433 0.0026
811 BRADYCARDIA 134 0.0025
812 HYPERSOMNIA 72 0.0025
813 HYPOTHYROIDISM 80 0.0025
814 GLAUCOMA 48 0.0025
815 MULTI-ORGAN FAILURE 43 0.0025
816 PRODUCT ADMINISTRATION ERROR 50 0.0025
817 MUSCULOSKELETAL DISORDER 47 0.0025
818 BLOOD CREATININE INCREASED 161 0.0025
819 ATRIAL FIBRILLATION 240 0.0025
820 INJECTION SITE MASS 91 0.0025
821 TREMOR 407 0.0024
822 LOSS OF CONSCIOUSNESS 314 0.0024
823 SPINAL FRACTURE 49 0.0024
824 CARDIOGENIC SHOCK 35 0.0024
825 METABOLIC ACIDOSIS 78 0.0024
826 PAIN IN JAW 69 0.0024
827 PRODUCT PRESCRIBING ERROR 58 0.0024
828 DEMENTIA 68 0.0024
829 MIDDLE INSOMNIA 45 0.0024
830 CHOLESTASIS 46 0.0024
831 EPISTAXIS 179 0.0024
832 RETCHING 51 0.0024
833 HYPOCALCAEMIA 45 0.0024
834 ERUCTATION 46 0.0024
835 PRODUCT SUBSTITUTION ISSUE 136 0.0024
836 UPPER LIMB FRACTURE 47 0.0024
837 HOSPITALISATION 362 0.0024
838 PRODUCT PRESCRIBING ISSUE 51 0.0023
839 COAGULOPATHY 39 0.0023
840 SKIN DISCOLOURATION 107 0.0023
841 THERAPY INTERRUPTED 166 0.0023
842 BLOOD TRIGLYCERIDES INCREASED 41 0.0023
843 BLOOD BILIRUBIN INCREASED 62 0.0023
844 CYANOSIS 36 0.0023
845 ACUTE RESPIRATORY FAILURE 44 0.0023
846 MENTAL IMPAIRMENT 55 0.0023
847 INTENTIONAL PRODUCT MISUSE 198 0.0023
848 SHOCK 52 0.0023
849 ACUTE KIDNEY INJURY 344 0.0022
850 ARRHYTHMIA 106 0.0022
851 FALL 745 0.0022
852 DRUG PRESCRIBING ERROR 43 0.0022
853 HIP FRACTURE 71 0.0022
854 CRYING 80 0.0022
855 ANGIOEDEMA 97 0.0022
856 LACRIMATION INCREASED 66 0.0022
857 CEREBRAL INFARCTION 53 0.0022
858 THERAPEUTIC RESPONSE UNEXPECTED 97 0.0022
859 NEOPLASM MALIGNANT 144 0.0022
860 DRUG INTERACTION 336 0.0021
861 THROMBOCYTOPENIA 236 0.0021
862 PROTEINURIA 40 0.0021
863 RENAL FAILURE ACUTE 89 0.0021
864 ACUTE RESPIRATORY DISTRESS SYNDROME 37 0.0021
865 OCULAR HYPERAEMIA 99 0.0021
866 FEAR 56 0.0021
867 VISION BLURRED 285 0.0021
868 HYPOTENSION 415 0.0021
869 URINARY RETENTION 69 0.0021
870 BONE PAIN 121 0.0021
871 THERAPY CESSATION 106 0.0021
872 RENAL DISORDER 96 0.0021
873 SKIN FISSURES 40 0.0020
874 EYE PAIN 115 0.0020
875 ACTIVITIES OF DAILY LIVING IMPAIRED 40 0.0020
876 ANAPHYLACTIC SHOCK 52 0.0020
877 RENAL FAILURE 267 0.0020
878 EYE PRURITUS 67 0.0020
879 URINARY INCONTINENCE 59 0.0020
880 BREAST CANCER FEMALE 53 0.0020
881 ABASIA 49 0.0020
882 BALANCE DISORDER 171 0.0020
883 GASTRIC DISORDER 67 0.0020
884 DEAFNESS 51 0.0019
885 RASH MACULO-PAPULAR 43 0.0019
886 MOVEMENT DISORDER 62 0.0019
887 WHITE BLOOD CELL COUNT DECREASED 206 0.0019
888 LUNG NEOPLASM MALIGNANT 78 0.0019
889 DISORIENTATION 75 0.0019
890 APHASIA 57 0.0019
891 AGEUSIA 47 0.0019
892 DRY EYE 94 0.0019
893 MOOD SWINGS 60 0.0019
894 HYPOXIA 66 0.0019
895 RESPIRATORY FAILURE 136 0.0019
896 PRODUCT QUALITY ISSUE 253 0.0019
897 PULMONARY OEDEMA 83 0.0019
898 ANGINA PECTORIS 53 0.0018
899 OVERDOSE 398 0.0018
900 HEPATIC FAILURE 55 0.0018
901 NEUROPATHY PERIPHERAL 172 0.0018
902 INCORRECT PRODUCT ADMINISTRATION DURATION 39 0.0018
903 MENTAL DISORDER 78 0.0018
904 ELECTROCARDIOGRAM QT PROLONGED 64 0.0018
905 INJURY ASSOCIATED WITH DEVICE 36 0.0018
906 PNEUMONIA ASPIRATION 44 0.0018
907 CHOKING 34 0.0017
908 HYPOACUSIS 75 0.0017
909 DRY SKIN 232 0.0017
910 EXPIRED PRODUCT ADMINISTERED 57 0.0017
911 ERECTILE DYSFUNCTION 43 0.0017
912 DISTURBANCE IN ATTENTION 89 0.0016
913 MUSCLE TWITCHING 38 0.0016
914 DYSSTASIA 48 0.0016
915 EYE DISORDER 54 0.0016
916 PAIN OF SKIN 44 0.0016
917 PRODUCT DOSE OMISSION IN ERROR 46 0.0016
918 DYSARTHRIA 61 0.0016
919 MUCOSAL INFLAMMATION 42 0.0016
920 MENSTRUATION IRREGULAR 42 0.0016
921 VAGINAL HAEMORRHAGE 68 0.0016
922 RESTLESSNESS 57 0.0016
923 ENCEPHALOPATHY 38 0.0015
924 CARDIAC FAILURE 124 0.0015
925 RESPIRATORY DISTRESS 42 0.0015
926 NEEDLE ISSUE 44 0.0015
927 CARDIAC DISORDER 141 0.0015
928 PRODUCT DOSE OMISSION 98 0.0015
929 DRUG ADMINISTRATION ERROR 46 0.0015
930 HALLUCINATION 112 0.0015
931 CEREBRAL HAEMORRHAGE 53 0.0015
932 MYELOSUPPRESSION 53 0.0015
933 EMOTIONAL DISORDER 45 0.0015
934 SKIN EXFOLIATION 122 0.0014
935 SPEECH DISORDER 74 0.0014
936 NERVOUS SYSTEM DISORDER 44 0.0014
937 FEBRILE NEUTROPENIA 93 0.0014
938 BLINDNESS 57 0.0014
939 HYPERKALAEMIA 49 0.0014
940 MOOD ALTERED 38 0.0014
941 ABNORMAL BEHAVIOUR 55 0.0014
942 EXTRA DOSE ADMINISTERED 56 0.0014
943 INTERNATIONAL NORMALISED RATIO INCREASED 39 0.0014
944 CONVULSION 78 0.0014
945 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 35 0.0014
946 SEIZURE 152 0.0013
947 NEUTROPENIA 176 0.0013
948 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 261 0.0013
949 HAEMATOMA 33 0.0013
950 IRRITABILITY 76 0.0013
951 AGITATION 92 0.0013
952 NEUTROPHIL COUNT DECREASED 51 0.0013
953 BLOOD CREATINE PHOSPHOKINASE INCREASED 36 0.0012
954 BREAST CANCER 116 0.0012
955 OSTEONECROSIS 40 0.0012
956 DISEASE PROGRESSION 144 0.0012
957 EYE IRRITATION 70 0.0012
958 SUICIDAL IDEATION 111 0.0012
959 ANGER 41 0.0012
960 RENAL INJURY 36 0.0012
961 MYOCARDIAL INFARCTION 211 0.0012
962 MULTIPLE SCLEROSIS 57 0.0012
963 ACUTE MYOCARDIAL INFARCTION 35 0.0012
964 COGNITIVE DISORDER 54 0.0012
965 PSYCHOTIC DISORDER 34 0.0012
966 PLATELET COUNT DECREASED 122 0.0011
967 PRODUCT STORAGE ERROR 100 0.0011
968 RHABDOMYOLYSIS 47 0.0011
969 VISUAL ACUITY REDUCED 37 0.0011
970 SKIN IRRITATION 51 0.0011
971 PROSTATE CANCER 88 0.0011
972 BLOOD GLUCOSE INCREASED 197 0.0010
973 CARDIAC FAILURE CONGESTIVE 83 0.0010
974 CARDIAC ARREST 85 0.0010
975 SUICIDE ATTEMPT 58 0.0010
976 INCORRECT ROUTE OF DRUG ADMINISTRATION 34 0.0010
977 HYPERGLYCAEMIA 34 0.0009
978 DYSKINESIA 37 0.0009
979 WITHDRAWAL SYNDROME 38 0.0009
980 HYPOGLYCAEMIA 43 0.0009
981 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
982 DERMATITIS ATOPIC 45 0.0009
983 DEATH 725 0.0008
984 EMOTIONAL DISTRESS 101 0.0008
985 SKIN BURNING SENSATION 54 0.0008
986 ACCIDENTAL EXPOSURE TO PRODUCT 62 0.0006
987 TOXICITY TO VARIOUS AGENTS 97 0.0006
988 DRUG DEPENDENCE 79 0.0005
989 DRUG ABUSE 38 0.0005
990 MALIGNANT NEOPLASM PROGRESSION 40 0.0004